[{"Assets_0_Q2_USD":"47063600000.0","CIK":"59478","CommonStockDividendsPerShareDeclared_1_Q2_USD":"1.96","CommonStockDividendsPerShareDeclared_2_Q2_USD":"1.96","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.06","EarningsPerShareBasic_2_Q2_USD":"3.17","EarningsPerShareDiluted_1_Q2_USD":"1.05","EarningsPerShareDiluted_2_Q2_USD":"3.16","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"283000000000.0","MinorityInterest_0_Q2_USD":"114500000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"3319900000.0","NetIncomeLoss_1_Q2_USD":"952500000.0","NetIncomeLoss_2_Q2_USD":"2855400000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_2_Q2_USD":"1769200000.0","RevenuesConverted_1_Q2_USD":"6488000000.0","RevenuesConverted_2_Q2_USD":"14298000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"8659200000.0","StockholdersEquity_0_Q2_USD":"8544700000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"902900000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"904400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"900300000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"902000000.0","filed":"20220804","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"ELI LILLY & CO","period":"20220630","qtrs":"0","uom":"USD"}]